GFAP and Alzheimer disease: A recent study with astrocytes derived from human-induced pluripotent stem cells (iPSCs) obtained from AD patients, reported an increase in calcium transients in response to glutamate, hypertrophy, and elevated glial fibrillary acidic protein (GFAP) expression due to monomeric and aggregated tau.